• 2,7-Dichlorodihydrofluorescein Diacetate for ROS Detection W

  2026-06-02

  2,7-Dichlorodihydrofluorescein diacetate (DCFH-DA) empowers researchers to accurately quantify intracellular ROS in live-cell systems, enabling sensitive, real-time assessment of oxidative stress and mitochondrial dysfunction. This article details practical workflows, advanced troubleshooting, and insights from recent neurodegenerative disease research that leverage DCFH-DA’s versatility across fluorescence microscopy, flow cytometry, and plate-based assays.

• Fingolimod (FTY720): Mechanisms and Innovations in Immunomod

  2026-06-02

  Explore the mechanistic innovations of Fingolimod (FTY720) as a sphingosine-1-phosphate receptor modulator, focusing on its dual impact on immune cell trafficking and neuroprotection. This article delivers a scientific perspective not found in current literature, with practical insights for translational research workflows.

• Dissecting Chuanxiong Cortex and Pith Mechanisms in CHD Prev

  2026-06-01

  This study leverages advanced SPME-GC×GC-MS and network pharmacology to reveal how volatile components of Chuanxiong's cortex and pith differentially target pathways relevant to coronary heart disease (CHD). The findings provide a molecular rationale for tissue-selective applications and highlight the importance of spatial metabolite distribution in traditional medicinal herbs.

• Analytical Advances for Rotigotine in Parkinson’s Disease Re

  2026-06-01

  This review systematically evaluates analytical methodologies for Rotigotine, a dopamine D2/D3 receptor agonist, focusing on impurity profiling, enantiomeric purity, and formulation stability. The findings provide essential guidance for the quality control and development of reliable pharmaceutical preparations in Parkinson’s disease research.

• Semi-Automated Screening of Fast-Dissociating Antibodies for

  2026-05-31

  Miyoshi et al. developed a semi-automated single-molecule microscopy workflow to screen for fast-dissociating yet highly specific monoclonal antibodies directly from hybridoma cultures. This approach advances multiplexed imaging and protein tagging, revealing transient biological processes that were previously inaccessible with conventional antibody assays.

• 3-Deazaneplanocin (DZNep): Strategic Epigenetic Modulation i

  2026-05-30

  This thought-leadership article dissects the mechanistic and translational value of 3-Deazaneplanocin (DZNep), spotlighting its unique dual inhibition of SAHH and EZH2, validated activity in cancer stem cell and hepatocellular carcinoma models, and protocol guidance for translational researchers. Integrating recent evidence on checkpoint kinase (CHK1) modulation in breast cancer, it offers a nuanced roadmap for leveraging DZNep in the evolving landscape of precision epigenetic oncology.

• Betaine Hydrochloride: Protocol Optimization in Enzyme Resea

  2026-05-29

  Betaine hydrochloride streamlines metabolic enzyme and protease workflows thanks to its high solubility and purity. Discover practical strategies and troubleshooting tips to maximize reproducibility and assay sensitivity in molecular biology labs.

• Phosbind Acrylamide: Transforming Phosphorylation Detection

  2026-05-29

  Phosbind Acrylamide enables antibody-free, high-resolution detection of protein phosphorylation states directly in SDS-PAGE, streamlining signal transduction research. Its compatibility with physiological pH and selectivity for phosphate groups make it ideal for rapid, quantitative analysis of dynamic signaling pathways.

• FITC-Concanavalin A (ConA) Conjugate: Technical Workflow Gui

  2026-05-28

  FITC-Concanavalin A (ConA) Conjugate enables selective, fluorescence-based detection of α-D-glucose and α-D-mannose residues on cell surfaces, streamlining carbohydrate profiling in immunofluorescence and flow cytometry. This reagent is not designed for non-carbohydrate targets or applications outside established glycan-detection workflows.

• Bone Transport Accelerates Diabetic Ulcer Healing via TGF-β1

  2026-05-28

  This study demonstrates that bone transport surgery enhances diabetic foot ulcer healing through TGF-β1–mediated angiogenic and osteo-immune coupling. The findings pinpoint the central role of TGF-β1/TGFBR1 signaling in orchestrating tissue repair, angiogenesis, and immune modulation, offering a mechanistic foundation for targeted intervention in chronic wound models.

• Structural Basis of ASCH Domain Proteins in N4-Acetylcytidin

  2026-05-27

  Meng et al. provide a structural and mechanistic dissection of ASCH domain-containing proteins, revealing the catalytic specificity of EcYqfB for free N4-Acetylcytidine (ac4C) nucleoside but not for its RNA-incorporated form. This work informs RNA epigenetics research by clarifying ac4C turnover and substrate selectivity among ASCH protein homologs.

• p53/PUMA-Mediated Synthetic Lethality via WRN Inhibition in

  2026-05-27

  The referenced study demonstrates that inhibition or depletion of Werner (WRN) helicase triggers p53/PUMA-dependent apoptosis specifically in mismatch repair-deficient (MSI) colorectal cancer cells. This mechanistic insight clarifies the synthetic lethality underlying WRN targeting in p53-wildtype MSI CRCs and supports WRN inhibition as a promising therapeutic approach for these genetically defined tumors.

• Phenacetin in Advanced Organoid PK Workflows: Protocols & In

  2026-05-26

  Phenacetin (N-(4-ethoxyphenyl)acetamide) is redefining pharmacokinetic research in human-relevant organoid systems, offering unmatched solubility and analytical precision. Discover optimized workflows, troubleshooting strategies, and the latest translational applications with APExBIO's high-purity Phenacetin as the benchmark compound.

• Z-DEVD-FMK as a Caspase-3 Inhibitor: Workflows & Neuroprotec

  2026-05-26

  Z-DEVD-FMK offers researchers a uniquely robust tool for dissecting apoptosis and neuroprotection pathways, combining irreversible caspase and calpain inhibition for advanced mechanistic insight. This guide translates the latest reference findings and experimental strategies into practical, optimized workflows for apoptosis assays and traumatic brain injury models.

• Dual-Action Kinase Inhibitors Promote p38α Dephosphorylation

  2026-05-25

  This study reveals that certain kinase inhibitors, by stabilizing specific inactive conformations of p38α MAP kinase, not only inhibit kinase activity but also accelerate its dephosphorylation by the WIP1 phosphatase. These findings introduce a new paradigm for designing dual-action inhibitors with enhanced specificity and therapeutic potential in kinase-driven diseases.

451 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page